Emalee A. Peterson

Associate

Contact

Practice Areas

Intellectual Property

Emalee Peterson is an associate in Axinn’s Intellectual Property group, where she focuses on patent litigation. She leverages her background in neuroscience and pharmaceutical research to help clients navigate complex life sciences matters.

Emalee A. Peterson

Associate

New York

Contact

Practice Areas

Intellectual Property

Download PDF Download V-Card

Emalee earned her JD from the University of New Hampshire Franklin Pierce School of Law, where she served as Chief Articles Editor of The University of New Hampshire Law Review and participated in the Daniel Webster Scholar Honors Program. During law school, she worked as a judicial extern with the Honorable Andrea K. Johnstone of the U.S. District Court for the District of New Hampshire. Prior to law school, she worked in academia and biotechnology studying treatment of neurodegenerative diseases. She holds a BS in Biology with a concentration in Neuroscience from Emmanuel College. Emalee was a summer associate with Axinn in 2024.

Education

JD, magna cum laude — University of New Hampshire Franklin Pierce School of Law (2025)
BS, magna cum laude — Emmanuel College (2018)

Admissions

New York

Profile

Education

Admissions

News & Insights

View all Insights

March 10, 2026

Back to the Well: FDA’s Draft Guidance on New Clinical Investigation Exclusivity

Introduction FDA recently published a new draft Guidance for Industry titled “New Clinical Investigation Exclusivity (3-Year Exclusivity)...

Axinn Viewpoints

Intellectual Property

February 12, 2026

No More Needles in Haystacks: Congress Requires FDA to Explain Q1/Q2 Sameness

Last week, on February 3, 2026, Congress passed the Consolidated Appropriations Act (“the Act”), providing generic drug manufacturers...

Axinn Viewpoints

Intellectual Property

February 6, 2026

Here We Go Again: Third Round of Inflation Reduction Act Drugs Listed

Pursuant to the Inflation Reduction Act (the “IRA”), the Secretary of Health and Human Services (“HHS”) and the Center for Medicare &...

Axinn Viewpoints

Intellectual Property

News & Insights

Related People

Ted Mathias

Partner

Ted Mathias serves as lead counsel in complex patent litigation, often managing cases involving more than 15 patents. He frequently handles matters at the intersection of patent and antitrust law, with a strong focus on advising clients in the pharmaceutical industry.

Learn more

Matthew S. Murphy

Partner

Matt Murphy leverages his prior experience as a research scientist to represent pharmaceutical, life sciences, and other companies in complex patent and trade secret litigation.

Recognized among IAM Patent 1000’s “World's Leading Patent Professionals,” Matt combines his litigation prowess and technical background to provide a 360-degree perspective on the legal trends and business challenges clients face. His experience in research and development for leading pharmaceutical and medical device companies makes him particularly adept at understanding the product development process and communicating highly technical information to judges and juries.

Learn more

Rebecca L. Clegg

Partner

Rebecca Clegg's practice focuses on complex intellectual property litigation and counseling, particularly in the fields of medical devices, pharmaceuticals, biotechnology, and semiconductors. Rebecca regularly litigates medical device and Hatch-Waxman Paragraph IV patent infringement suits. She also has experience representing clients in commercial litigation cases.

Learn more

Sara Natour

Associate

Sara Natour is an associate in Axinn’s Intellectual Property group. Her practice focuses on trademark and patent litigation involving pharmaceuticals and technology.

Learn more